FindTrial
Sign In

Application of modified surgical approach in radical resection of Siewert type II adenocarcinoma of esophagogastric junction

Application of modified surgical approach in radical resection of Siewert type II adenocarcinoma of esophagogastric junction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101841
Enrollment
Unknown
Registered
2025-04-30
Start date
2024-02-21
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenocarcinoma of esophagogastric junction

Interventions

single position transthoracic approach group:None
transabdominal approach group:None

Sponsors

Henan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed as Siewert type II AEG; 2. Tumor involvement of EGJ; 3. The lymph node dissection range is D2 lower mediastinal lymph node; 4. No distant metastasis, no middle and upper mediastinal lymphadenopathy; 5. The pathological T stage is TI-T4a, the length of the tumor is =4cm, and the length of the esophagus is <3cm; 6. Complete surgical and follow-up data.

Exclusion criteria

Exclusion criteria: 1. Late pathological stage, preoperative neoadjuvant chemotherapy; 2. After palliative surgery; 3. Gastroscopy or pathological examination has not confirmed adenocarcinoma; 4. Distant metastasis of the tumor; 5. Have a history of other malignant tumors; 6. Lack of clinicopathological data.

Design outcomes

Primary

MeasureTime frame
Operation time;Intraoperative blood loss;Total incidence of postoperative complications;Length of postoperative hospital stay;Total lymph node dissection;—

Countries

China

Contacts

Public ContactHaitao Wei

Henan University

10210051@vip.henu.edu.cn+86 137 0378 6236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026